APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Loperamide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Loperamide Market Analysis and Forecast 2026-2032

Report ID 174008930231 December 2025198 pages

Choose your research edition.

Industry ResearchLoperamide Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Loperamide Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Loperamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Loperamide Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Loperamide Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Loperamide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Loperamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Loperamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Loperamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Loperamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Loperamide include Teva, Sun Pharmaceutical, Johnson & Johnson, Mylan, Perrigo, LNK International, Bionpharma and Aurobindo Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Loperamide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Loperamide, also provides the sales of main regions and countries. Of the upcoming market potential for Loperamide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Loperamide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Loperamide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Loperamide sales, projected growth trends, production technology, application and end-user industry.

Loperamide Segment by Company

Teva

Sun Pharmaceutical

Johnson & Johnson

Mylan

Perrigo

LNK International

Bionpharma

Aurobindo Pharma

Loperamide Segment by Type

Solution

Tablet

Granule

Capsule

Loperamide Segment by Application

Pharmacies

Hospitals

Clinics

Loperamide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loperamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Loperamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loperamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Loperamide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Loperamide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Loperamide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Loperamide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Solution Major Manufacturers Table 3. Tablet Major Manufacturers Table 4. Granule Major Manufacturers Table 5. Capsule Major Manufacturers Table 6. Global Loperamide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmacies Major Manufacturers Table 8. Hospitals Major Manufacturers Table 9. Clinics Major Manufacturers Table 10. Loperamide Industry Trends Table 11. Loperamide Industry Drivers Table 12. Loperamide Industry Opportunities and Challenges Table 13. Loperamide Industry Restraints Table 14. Global Loperamide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Loperamide Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Loperamide Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Loperamide Revenue Market Share by Region (2021-2026) Table 18. Global Loperamide Revenue Market Share by Region (2027-2032) Table 19. Global Loperamide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 20. Global Loperamide Sales by Region (2021-2026) & (Tons) Table 21. Global Loperamide Sales by Region (2027-2032) & (Tons) Table 22. Global Loperamide Sales Market Share by Region (2021-2026) Table 23. Global Loperamide Sales Market Share by Region (2027-2032) Table 24. Global Loperamide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Loperamide Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Loperamide Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Loperamide Sales Market Share by Manufacturers (2021-2026) Table 28. Global Loperamide Sales Price (US$/g) of Manufacturers (2021-2026) Table 29. Global Loperamide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Loperamide Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Loperamide Manufacturers, Product Type & Application Table 32. Global Loperamide Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Loperamide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Loperamide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Loperamide Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Loperamide Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Loperamide Revenue Market Share by Type (2021-2026) Table 39. Global Loperamide Revenue Market Share by Type (2027-2032) Table 40. Global Loperamide Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 41. Global Loperamide Sales by Type (2021-2026) & (Tons) Table 42. Global Loperamide Sales by Type (2027-2032) & (Tons) Table 43. Global Loperamide Sales Market Share by Type (2021-2026) Table 44. Global Loperamide Sales Market Share by Type (2027-2032) Table 45. Global Loperamide Price by Type (2021-2026) & (US$/g) Table 46. Global Loperamide Price by Type (2027-2032) & (US$/g) Table 47. Global Loperamide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Loperamide Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Loperamide Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Loperamide Revenue Market Share by Application (2021-2026) Table 51. Global Loperamide Revenue Market Share by Application (2027-2032) Table 52. Global Loperamide Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 53. Global Loperamide Sales by Application (2021-2026) & (Tons) Table 54. Global Loperamide Sales by Application (2027-2032) & (Tons) Table 55. Global Loperamide Sales Market Share by Application (2021-2026) Table 56. Global Loperamide Sales Market Share by Application (2027-2032) Table 57. Global Loperamide Price by Application (2021-2026) & (US$/g) Table 58. Global Loperamide Price by Application (2027-2032) & (US$/g) Table 59. Teva Company Information Table 60. Teva Business Overview Table 61. Teva Loperamide Sales (Tons), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 62. Teva Loperamide Product Portfolio Table 63. Teva Recent Development Table 64. Sun Pharmaceutical Company Information Table 65. Sun Pharmaceutical Business Overview Table 66. Sun Pharmaceutical Loperamide Sales (Tons), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 67. Sun Pharmaceutical Loperamide Product Portfolio Table 68. Sun Pharmaceutical Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Loperamide Sales (Tons), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Loperamide Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Mylan Company Information Table 75. Mylan Business Overview Table 76. Mylan Loperamide Sales (Tons), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 77. Mylan Loperamide Product Portfolio Table 78. Mylan Recent Development Table 79. Perrigo Company Information Table 80. Perrigo Business Overview Table 81. Perrigo Loperamide Sales (Tons), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 82. Perrigo Loperamide Product Portfolio Table 83. Perrigo Recent Development Table 84. LNK International Company Information Table 85. LNK International Business Overview Table 86. LNK International Loperamide Sales (Tons), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 87. LNK International Loperamide Product Portfolio Table 88. LNK International Recent Development Table 89. Bionpharma Company Information Table 90. Bionpharma Business Overview Table 91. Bionpharma Loperamide Sales (Tons), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 92. Bionpharma Loperamide Product Portfolio Table 93. Bionpharma Recent Development Table 94. Aurobindo Pharma Company Information Table 95. Aurobindo Pharma Business Overview Table 96. Aurobindo Pharma Loperamide Sales (Tons), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 97. Aurobindo Pharma Loperamide Product Portfolio Table 98. Aurobindo Pharma Recent Development Table 99. North America Loperamide Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Loperamide Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Loperamide Sales by Type (2021-2026) & (Tons) Table 102. North America Loperamide Sales by Type (2027-2032) & (Tons) Table 103. North America Loperamide Sales Price by Type (2021-2026) & (US$/g) Table 104. North America Loperamide Sales Price by Type (2027-2032) & (US$/g) Table 105. North America Loperamide Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Loperamide Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Loperamide Sales by Application (2021-2026) & (Tons) Table 108. North America Loperamide Sales by Application (2027-2032) & (Tons) Table 109. North America Loperamide Sales Price by Application (2021-2026) & (US$/g) Table 110. North America Loperamide Sales Price by Application (2027-2032) & (US$/g) Table 111. North America Loperamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Loperamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America Loperamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America Loperamide Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 115. North America Loperamide Sales by Country (2021-2026) & (Tons) Table 116. North America Loperamide Sales by Country (2027-2032) & (Tons) Table 117. North America Loperamide Sales Price by Country (2021-2026) & (US$/g) Table 118. North America Loperamide Sales Price by Country (2027-2032) & (US$/g) Table 119. United States Loperamide Revenue (2021-2032) & (US$ Million) Table 120. Canada Loperamide Revenue (2021-2032) & (US$ Million) Table 121. Europe Loperamide Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Loperamide Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Loperamide Sales by Type (2021-2026) & (Tons) Table 124. Europe Loperamide Sales by Type (2027-2032) & (Tons) Table 125. Europe Loperamide Sales Price by Type (2021-2026) & (US$/g) Table 126. Europe Loperamide Sales Price by Type (2027-2032) & (US$/g) Table 127. Europe Loperamide Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Loperamide Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Loperamide Sales by Application (2021-2026) & (Tons) Table 130. Europe Loperamide Sales by Application (2027-2032) & (Tons) Table 131. Europe Loperamide Sales Price by Application (2021-2026) & (US$/g) Table 132. Europe Loperamide Sales Price by Application (2027-2032) & (US$/g) Table 133. Europe Loperamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Loperamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Loperamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Loperamide Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 137. Europe Loperamide Sales by Country (2021-2026) & (Tons) Table 138. Europe Loperamide Sales by Country (2027-2032) & (Tons) Table 139. Europe Loperamide Sales Price by Country (2021-2026) & (US$/g) Table 140. Europe Loperamide Sales Price by Country (2027-2032) & (US$/g) Table 141. Germany Loperamide Revenue (2021-2032) & (US$ Million) Table 142. France Loperamide Revenue (2021-2032) & (US$ Million) Table 143. U.K. Loperamide Revenue (2021-2032) & (US$ Million) Table 144. Italy Loperamide Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Loperamide Revenue (2021-2032) & (US$ Million) Table 146. Nordic Countries Loperamide Revenue (2021-2032) & (US$ Million) Table 147. China Loperamide Revenue by Type (2021-2026) & (US$ Million) Table 148. China Loperamide Revenue by Type (2027-2032) & (US$ Million) Table 149. China Loperamide Sales by Type (2021-2026) & (Tons) Table 150. China Loperamide Sales by Type (2027-2032) & (Tons) Table 151. China Loperamide Sales Price by Type (2021-2026) & (US$/g) Table 152. China Loperamide Sales Price by Type (2027-2032) & (US$/g) Table 153. China Loperamide Revenue by Application (2021-2026) & (US$ Million) Table 154. China Loperamide Revenue by Application (2027-2032) & (US$ Million) Table 155. China Loperamide Sales by Application (2021-2026) & (Tons) Table 156. China Loperamide Sales by Application (2027-2032) & (Tons) Table 157. China Loperamide Sales Price by Application (2021-2026) & (US$/g) Table 158. China Loperamide Sales Price by Application (2027-2032) & (US$/g) Table 159. Asia Loperamide Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia Loperamide Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia Loperamide Sales by Type (2021-2026) & (Tons) Table 162. Asia Loperamide Sales by Type (2027-2032) & (Tons) Table 163. Asia Loperamide Sales Price by Type (2021-2026) & (US$/g) Table 164. Asia Loperamide Sales Price by Type (2027-2032) & (US$/g) Table 165. Asia Loperamide Revenue by Application (2021-2026) & (US$ Million) Table 166. Asia Loperamide Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Loperamide Sales by Application (2021-2026) & (Tons) Table 168. Asia Loperamide Sales by Application (2027-2032) & (Tons) Table 169. Asia Loperamide Sales Price by Application (2021-2026) & (US$/g) Table 170. Asia Loperamide Sales Price by Application (2027-2032) & (US$/g) Table 171. Asia Loperamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Loperamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Asia Loperamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Asia Loperamide Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 175. Asia Loperamide Sales by Country (2021-2026) & (Tons) Table 176. Asia Loperamide Sales by Country (2027-2032) & (Tons) Table 177. Asia Loperamide Sales Price by Country (2021-2026) & (US$/g) Table 178. Asia Loperamide Sales Price by Country (2027-2032) & (US$/g) Table 179. Japan Loperamide Revenue (2021-2032) & (US$ Million) Table 180. South Korea Loperamide Revenue (2021-2032) & (US$ Million) Table 181. India Loperamide Revenue (2021-2032) & (US$ Million) Table 182. Australia Loperamide Revenue (2021-2032) & (US$ Million) Table 183. China Taiwan Loperamide Revenue (2021-2032) & (US$ Million) Table 184. Southeast Asia Loperamide Revenue (2021-2032) & (US$ Million) Table 185. SAMEA Loperamide Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA Loperamide Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA Loperamide Sales by Type (2021-2026) & (Tons) Table 188. SAMEA Loperamide Sales by Type (2027-2032) & (Tons) Table 189. SAMEA Loperamide Sales Price by Type (2021-2026) & (US$/g) Table 190. SAMEA Loperamide Sales Price by Type (2027-2032) & (US$/g) Table 191. SAMEA Loperamide Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA Loperamide Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA Loperamide Sales by Application (2021-2026) & (Tons) Table 194. SAMEA Loperamide Sales by Application (2027-2032) & (Tons) Table 195. SAMEA Loperamide Sales Price by Application (2021-2026) & (US$/g) Table 196. SAMEA Loperamide Sales Price by Application (2027-2032) & (US$/g) Table 197. SAMEA Loperamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA Loperamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. SAMEA Loperamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. SAMEA Loperamide Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 201. SAMEA Loperamide Sales by Country (2021-2026) & (Tons) Table 202. SAMEA Loperamide Sales by Country (2027-2032) & (Tons) Table 203. SAMEA Loperamide Sales Price by Country (2021-2026) & (US$/g) Table 204. SAMEA Loperamide Sales Price by Country (2027-2032) & (US$/g) Table 205. Brazil Loperamide Revenue (2021-2032) & (US$ Million) Table 206. Argentina Loperamide Revenue (2021-2032) & (US$ Million) Table 207. Chile Loperamide Revenue (2021-2032) & (US$ Million) Table 208. Colombia Loperamide Revenue (2021-2032) & (US$ Million) Table 209. Peru Loperamide Revenue (2021-2032) & (US$ Million) Table 210. Saudi Arabia Loperamide Revenue (2021-2032) & (US$ Million) Table 211. Israel Loperamide Revenue (2021-2032) & (US$ Million) Table 212. UAE Loperamide Revenue (2021-2032) & (US$ Million) Table 213. Turkey Loperamide Revenue (2021-2032) & (US$ Million) Table 214. Iran Loperamide Revenue (2021-2032) & (US$ Million) Table 215. Egypt Loperamide Revenue (2021-2032) & (US$ Million) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Loperamide Distributors List Table 219. Loperamide Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Loperamide Image Figure 2. Global Loperamide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Loperamide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Solution Image Figure 5. Tablet Image Figure 6. Granule Image Figure 7. Capsule Image Figure 8. Global Loperamide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Loperamide Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmacies Image Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Global Loperamide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Loperamide Revenue (2021-2032) & (US$ Million) Figure 15. Global Loperamide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Loperamide Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Loperamide Revenue Market Share by Region (2021-2032) Figure 18. Global Loperamide Sales (2021-2032) & (Tons) Figure 19. Global Loperamide Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 20. Global Loperamide Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Loperamide Sales YoY (2021-2032) & (Tons) Figure 22. Europe Loperamide Sales YoY (2021-2032) & (Tons) Figure 23. China Loperamide Sales YoY (2021-2032) & (Tons) Figure 24. Asia (Excluding China) Loperamide Sales YoY (2021-2032) & (Tons) Figure 25. South America, Middle East and Africa Loperamide Sales YoY (2021-2032) & (Tons) Figure 26. Global Loperamide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Loperamide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Loperamide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Loperamide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Loperamide Revenue Market Share by Type (2021-2032) Figure 32. Global Loperamide Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 33. Global Loperamide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Loperamide Sales Market Share by Type (2021-2032) Figure 35. Global Loperamide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Loperamide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Loperamide Revenue Market Share by Application (2021-2032) Figure 38. Global Loperamide Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 39. Global Loperamide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Loperamide Sales Market Share by Application (2021-2032) Figure 41. North America Loperamide Revenue Share by Type (2021-2032) Figure 42. North America Loperamide Sales Share by Type (2021-2032) Figure 43. North America Loperamide Revenue Share by Application (2021-2032) Figure 44. North America Loperamide Sales Share by Application (2021-2032) Figure 45. North America Loperamide Revenue Share by Country (2021-2032) Figure 46. North America Loperamide Sales Share by Country (2021-2032) Figure 47. Europe Loperamide Revenue Share by Type (2021-2032) Figure 48. Europe Loperamide Sales Share by Type (2021-2032) Figure 49. Europe Loperamide Revenue Share by Application (2021-2032) Figure 50. Europe Loperamide Sales Share by Application (2021-2032) Figure 51. Europe Loperamide Revenue Share by Country (2021-2032) Figure 52. Europe Loperamide Sales Share by Country (2021-2032) Figure 53. China Loperamide Revenue Share by Type (2021-2032) Figure 54. China Loperamide Sales Share by Type (2021-2032) Figure 55. China Loperamide Revenue Share by Application (2021-2032) Figure 56. China Loperamide Sales Share by Application (2021-2032) Figure 57. Asia Loperamide Revenue Share by Type (2021-2032) Figure 58. Asia Loperamide Sales Share by Type (2021-2032) Figure 59. Asia Loperamide Revenue Share by Application (2021-2032) Figure 60. Asia Loperamide Sales Share by Application (2021-2032) Figure 61. Asia Loperamide Revenue Share by Country (2021-2032) Figure 62. Asia Loperamide Sales Share by Country (2021-2032) Figure 63. SAMEA Loperamide Revenue Share by Type (2021-2032) Figure 64. SAMEA Loperamide Sales Share by Type (2021-2032) Figure 65. SAMEA Loperamide Revenue Share by Application (2021-2032) Figure 66. SAMEA Loperamide Sales Share by Application (2021-2032) Figure 67. SAMEA Loperamide Revenue Share by Country (2021-2032) Figure 68. SAMEA Loperamide Sales Share by Country (2021-2032) Figure 69. Loperamide Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Loperamide Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Solution
  • Tablet
  • Granule
  • Capsule
Applications
  • Pharmacies
  • Hospitals
  • Clinics
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Mylan
  • Perrigo
  • LNK International
  • Bionpharma
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Loperamide Market by Type
  3. 1.2.1 Global Loperamide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Solution
  5. 1.2.3 Tablet
  6. 1.2.4 Granule
  7. 1.2.5 Capsule
  8. 1.3 Loperamide Market by Application
  9. 1.3.1 Global Loperamide Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmacies
  11. 1.3.3 Hospitals
  12. 1.3.4 Clinics
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Loperamide Market Dynamics
  1. 2.1 Loperamide Industry Trends
  2. 2.2 Loperamide Industry Drivers
  3. 2.3 Loperamide Industry Opportunities and Challenges
  4. 2.4 Loperamide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Loperamide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Loperamide Revenue by Region
  3. 3.2.1 Global Loperamide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Loperamide Revenue by Region (2021-2026)
  5. 3.2.3 Global Loperamide Revenue by Region (2027-2032)
  6. 3.2.4 Global Loperamide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Loperamide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Loperamide Sales by Region
  9. 3.4.1 Global Loperamide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Loperamide Sales by Region (2021-2026)
  11. 3.4.3 Global Loperamide Sales by Region (2027-2032)
  12. 3.4.4 Global Loperamide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Loperamide Revenue by Manufacturers
  2. 4.1.1 Global Loperamide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Loperamide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Loperamide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Loperamide Sales by Manufacturers
  6. 4.2.1 Global Loperamide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Loperamide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Loperamide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Loperamide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Loperamide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Loperamide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Loperamide Manufacturers, Product Type & Application
  13. 4.7 Global Loperamide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Loperamide Market CR5 and HHI
  16. 4.8.2 2025 Loperamide Tier 1, Tier 2, and Tier 3
5 Loperamide Market by Type
  1. 5.1 Global Loperamide Revenue by Type
  2. 5.1.1 Global Loperamide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Loperamide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Loperamide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Loperamide Sales by Type
  6. 5.2.1 Global Loperamide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Loperamide Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Loperamide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Loperamide Price by Type
6 Loperamide Market by Application
  1. 6.1 Global Loperamide Revenue by Application
  2. 6.1.1 Global Loperamide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Loperamide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Loperamide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Loperamide Sales by Application
  6. 6.2.1 Global Loperamide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Loperamide Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Loperamide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Loperamide Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Loperamide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Loperamide Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Loperamide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Loperamide Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Loperamide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Loperamide Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Loperamide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Loperamide Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Perrigo
  26. 7.5.1 Perrigo Company Information
  27. 7.5.2 Perrigo Business Overview
  28. 7.5.3 Perrigo Loperamide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Perrigo Loperamide Product Portfolio
  30. 7.5.5 Perrigo Recent Developments
  31. 7.6 LNK International
  32. 7.6.1 LNK International Company Information
  33. 7.6.2 LNK International Business Overview
  34. 7.6.3 LNK International Loperamide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 LNK International Loperamide Product Portfolio
  36. 7.6.5 LNK International Recent Developments
  37. 7.7 Bionpharma
  38. 7.7.1 Bionpharma Company Information
  39. 7.7.2 Bionpharma Business Overview
  40. 7.7.3 Bionpharma Loperamide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bionpharma Loperamide Product Portfolio
  42. 7.7.5 Bionpharma Recent Developments
  43. 7.8 Aurobindo Pharma
  44. 7.8.1 Aurobindo Pharma Company Information
  45. 7.8.2 Aurobindo Pharma Business Overview
  46. 7.8.3 Aurobindo Pharma Loperamide Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Aurobindo Pharma Loperamide Product Portfolio
  48. 7.8.5 Aurobindo Pharma Recent Developments
8 North America
  1. 8.1 North America Loperamide Market Size by Type
  2. 8.1.1 North America Loperamide Revenue by Type (2021-2032)
  3. 8.1.2 North America Loperamide Sales by Type (2021-2032)
  4. 8.1.3 North America Loperamide Price by Type (2021-2032)
  5. 8.2 North America Loperamide Market Size by Application
  6. 8.2.1 North America Loperamide Revenue by Application (2021-2032)
  7. 8.2.2 North America Loperamide Sales by Application (2021-2032)
  8. 8.2.3 North America Loperamide Price by Application (2021-2032)
  9. 8.3 North America Loperamide Market Size by Country
  10. 8.3.1 North America Loperamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Loperamide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Loperamide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Loperamide Market Size by Type
  2. 9.1.1 Europe Loperamide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Loperamide Sales by Type (2021-2032)
  4. 9.1.3 Europe Loperamide Price by Type (2021-2032)
  5. 9.2 Europe Loperamide Market Size by Application
  6. 9.2.1 Europe Loperamide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Loperamide Sales by Application (2021-2032)
  8. 9.2.3 Europe Loperamide Price by Application (2021-2032)
  9. 9.3 Europe Loperamide Market Size by Country
  10. 9.3.1 Europe Loperamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Loperamide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Loperamide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Loperamide Market Size by Type
  2. 10.1.1 China Loperamide Revenue by Type (2021-2032)
  3. 10.1.2 China Loperamide Sales by Type (2021-2032)
  4. 10.1.3 China Loperamide Price by Type (2021-2032)
  5. 10.2 China Loperamide Market Size by Application
  6. 10.2.1 China Loperamide Revenue by Application (2021-2032)
  7. 10.2.2 China Loperamide Sales by Application (2021-2032)
  8. 10.2.3 China Loperamide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Loperamide Market Size by Type
  2. 11.1.1 Asia Loperamide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Loperamide Sales by Type (2021-2032)
  4. 11.1.3 Asia Loperamide Price by Type (2021-2032)
  5. 11.2 Asia Loperamide Market Size by Application
  6. 11.2.1 Asia Loperamide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Loperamide Sales by Application (2021-2032)
  8. 11.2.3 Asia Loperamide Price by Application (2021-2032)
  9. 11.3 Asia Loperamide Market Size by Country
  10. 11.3.1 Asia Loperamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Loperamide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Loperamide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Loperamide Market Size by Type
  2. 12.1.1 SAMEA Loperamide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Loperamide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Loperamide Price by Type (2021-2032)
  5. 12.2 SAMEA Loperamide Market Size by Application
  6. 12.2.1 SAMEA Loperamide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Loperamide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Loperamide Price by Application (2021-2032)
  9. 12.3 SAMEA Loperamide Market Size by Country
  10. 12.3.1 SAMEA Loperamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Loperamide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Loperamide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Loperamide Value Chain Analysis
  2. 13.1.1 Loperamide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Loperamide Production Mode & Process
  6. 13.2 Loperamide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Loperamide Distributors
  9. 13.2.3 Loperamide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst